Evidence map›Paper›PMID 35110419›Full record

ArticleJournal of immunology (Baltimore, Md. : 1950)2022

Group B

Xin Xu, Alexander L Lewis Marffy, Andrew Keightley, Alex J McCarthy, Brian V Geisbrecht

Open access · bronzeAbstract read
In one paragraph

Article in Journal of immunology (Baltimore, Md. : 1950), 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
1.0field-weighted citation impact, top 25% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 5 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 3 institutions in 2 countries.

Xin XuDepartment of Biochemistry & Molecular Biophysics, Kansas State University, Manhattan, KS.ORCID 0000-0002-0728-0821
Alexander L Lewis MarffyDepartment of Infectious Diseases, Section of Molecular Microbiology, MRC Centre for Molecular Bacteriology and Infection, Imperial College London, London, United Kingdom; and.
Andrew KeightleyDepartment of Ophthalmology, School of Medicine, University of Missouri-Kansas City, Kansas City, MO.
Alex J McCarthyDepartment of Infectious Diseases, Section of Molecular Microbiology, MRC Centre for Molecular Bacteriology and Infection, Imperial College London, London, United Kingdom; and.ORCID 0000-0002-4105-3737
Brian V GeisbrechtDepartment of Biochemistry & Molecular Biophysics, Kansas State University, Manhattan, KS; geisbrechtb@ksu.edu.
Imperial College London · GBKansas State University · USUniversity of Missouri–Kansas City · US

Funding

Structure/Function Studies of LILRs Enabled by a Bacterially-Derived LigandR21AI155828 · NIAID · KANSAS STATE UNIVERSITY · PI GEISBRECHT, BRIAN V · 2021 to 2022
$380k
Biotechnology and Biological Sciences Research Council BB/V006495/1NIAID NIH HHS R21 AI155828
6 · The paper itself

Abstract

The β protein from group B

Indexed as

Bacterial ProteinsBinding SitesComplement C3bComplement Factor HHumansImmune EvasionMembrane ProteinsNeutrophilsOpsonizationProtein BindingProtein DomainsStreptococcal InfectionsStreptococcus agalactiaeBacterial ProteinsCFH protein, humanComplement C3bComplement Factor HMembrane ProteinsSpb1 protein, Streptococcus agalactiae

Identifiers

PMID35110419
PMCPMC8881398
OpenAlexW4210729515

What Socratic holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.